Innate immune defects in atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 118, Issue 1, 2006, Pages 202-208

  McGirt, Laura Y ^a   Beck, Lisa A ^b  

^a Division of Allergy and Clinical Immunology   (Italy)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic dermatitis; eczema; innate immunity

Indexed keywords

ALPHA DEFENSIN; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BACTERIAL ANTIGEN; BETA DEFENSIN; CALCINEURIN INHIBITOR; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD14 ANTIGEN; CERAMIDE; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOGLOBULIN E; INTERLEUKIN 1; LECTIN; MANNAN BINDING LECTIN; PEPTIDOGLYCAN RECOGNITION PROTEIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN; SPHINGOSINE; SUPERANTIGEN; TACROLIMUS; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CANDIDA; COMPLEMENT ACTIVATION; DISEASE PREDISPOSITION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE DEFICIENCY; INFLAMMATION; INNATE IMMUNITY; MALASSEZIA; MOLLUSCIPOXVIRUS; MYCOSIS; NEUTROPHIL; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STRATUM CORNEUM; TH2 CELL; VACCINATION; VACCINIA VIRUS; VIRUS INFECTION;

ANTIGENS, CD14; BETA-DEFENSINS; DERMATITIS, ATOPIC; EPIDERMIS; HUMANS; IMMUNITY, NATURAL; MANNOSE-BINDING LECTIN; NEUTROPHILS; RECEPTORS, INTERLEUKIN-1; TOLL-LIKE RECEPTORS;

EID: 33745398503     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.04.033     Document Type: Review

References (66)

1. Leung D.Y. Infection in atopic dermatitis. Curr Opin Pediatr 15 (2003) 399-404
2. Sohn M.H., Kim C.H., Kim W.K., Jang G.C., and Kim K.E. Effect of staphylococcal enterotoxin B on specific antibody production in children with atopic dermatitis. Allergy Asthma Proc 24 (2003) 67-71
3. Bunikowski R., Mielke M., Skarabis H., Herz U., Bergmann R.L., Wahn U., et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 103 (1999) 119-124
4. Hauk P.J., Hamid Q.A., Chrousos G.P., and Leung D.Y. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 105 (2000) 782-787
5. Breuer K., Haussler S., Kapp A., and Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 147 (2002) 55-61
6. Lever R., Hadley K., Downey D., and Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 119 (1988) 189-198
7. Wollenberg A., Wetzel S., Burgdorf W.H., and Haas J. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J Allergy Clin Immunol 112 (2003) 667-674
8. Clemmensen O.J., and Hjorth N. Treatment of atopic dermatitis of the head and neck with ketoconazole in patients with type I sensitivity to Pityrosporum orbiculare. Semin Dermatol 2 (1983) 26-29
9. Johansson C., Sandstrom M.H., Bartosik J., Sarnhult T., Christiansen J., Zargari A., et al. Atopy patch test reactions to Malassezia allergens differentiate subgroups of atopic dermatitis patients. Br J Dermatol 148 (2003) 479-488
10. Arzumanyan V.G., Magarshak O.O., and Semenov B.F. Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs. Bull Exp Biol Med 129 (2000) 601-604
11. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54 (1989) 1-13
12. Medzhitov R., and Janeway Jr. C. Innate immunity. N Engl J Med 343 (2000) 338-344
13. Esche C., Stellato C., and Beck L.A. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125 (2005) 615-628
14. Elias P.M. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 125 (2005) 183-200
15. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
16. Arikawa J., Ishibashi M., Kawashima M., Takagi Y., Ichikawa Y., and Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 119 (2002) 433-439
17. Hara J., Higuchi K., Okamoto R., Kawashima M., and Imokawa G. High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115 (2000) 406-413
18. Imokawa G., Abe A., Jin K., Higaki Y., Kawashima M., and Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J Invest Dermatol 96 (1991) 523-526
19. Lu J., Teh C., Kishore U., and Reid K.B. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 1572 (2002) 387-400
20. Gadjeva M., Paludan S.R., Thiel S., Slavov V., Ruseva M., Eriksson K., et al. Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol 138 (2004) 304-311
21. Shi L., Takahashi K., Dundee J., Shahroor-Karni S., Thiel S., Jensenius J.C., et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 199 (2004) 1379-1390
22. Hogaboam C.M., Takahashi K., Ezekowitz R.A., Kunkel S.L., and Schuh J.M. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J Leukoc Biol 75 (2004) 805-814
23. Aittoniemi J., Soranummi H., Rovio A.T., Hurme M., Pessi T., Nieminen M., et al. Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults. Clin Exp Immunol 142 (2005) 120-124
24. Gardner E.T., Stierman L.M., Jovanovic B., Shannon J.J., Saltoun C.A., Grammer L.C., et al. Reduced serum levels of innate immune molecules in subjects with frequent asthma exacerbations. [abstract]. J Allergy Clin Immunol 117 suppl (2006) S14
25. Brandrup F., Homburg K.M., Wang P., Garred P., and Madsen H.O. Mannan-binding lectin deficiency associated with recurrent cutaneous abscesses, prurigo and possibly atopic dermatitis. A family study. Br J Dermatol 140 (1999) 180-181
26. McInturff J.E., Modlin R.L., and Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125 (2005) 1-8
27. Kollisch G., Kalali B.N., Voelcker V., Wallich R., Behrendt H., Ring J., et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114 (2005) 531-541
28. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006) 341-348
29. Takeuchi O., Hoshino K., and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165 (2000) 5392-5396
30. Werfel T., Heeg K., Neumaier M., and Renz H. 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 113 (2004) 565-567
31. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171 (2003) 3262-3269
32. McGirt LY BM, Bankova LG, Beck LA. Keratinocyte expression of receptors relevant for the innate immune response to Staphylococcus aureus in subjects with atopic dermatitis [abstract]. J Invest Dermatol 2006;126:116.
33. Miller L.S., O'Connell R.M., Gutierrez M.A., Pietras E.M., Shahangian A., Gross C.E., et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24 (2006) 79-91
34. Terui T., Hirao T., Sato Y., Uesugi T., Honda M., Iguchi M., et al. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Exp Dermatol 7 (1998) 327-334
35. Park H.J., Kim H.J., Lee J.H., Lee J.Y., Cho B.K., Kang J.S., et al. Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. J Invest Dermatol 124 (2005) 751-755
36. Girardin S.E., and Philpott D.J. Mini-review: the role of peptidoglycan recognition in innate immunity. Eur J Immunol 34 (2004) 1777-1782
37. Song P.I., Prado R., Kang Y., Kolot A., Armstrong C.A., and Ansel J.C. Keratinocytes express nucleotide-binding oligomerization domain (NOD) 1 and 2: implications for cutaneous innate immunity. [abstract]. J Invest Dermatol 122 (2004) A754
38. Voss E., Wehkamp K., Schroder J.M., and Harder J. Induction of the skin-derived antimicrobial peptide human beta-definsin-2 via NOD2/CARD15. [abstract]. J Invest Dermatol 123 (2004) A204
39. Weidinger S., Klopp N., Rummler L., Wagenpfeil S., Novak N., Baurecht H.J., et al. Association of NOD1 polymorphisms with atopic eczema and related phenotypes. J Allergy Clin Immunol 116 (2005) 177-184
40. Koppelman G.H., and Postma D.S. The genetics of CD14 in allergic disease. Curr Opin Allergy Clin Immunol 3 (2003) 347-352
41. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J Biol Chem 278 (2003) 15587-15594
42. Dziarski R. Recognition of bacterial peptidoglycan by the innate immune system. Cell Mol Life Sci 60 (2003) 1793-1804
43. Tschopp J., Martinon F., and Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4 (2003) 95-104
44. Song P.I., Park Y.M., Abraham T., Harten B., Zivony A., Neparidze N., et al. Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 119 (2002) 424-432
45. Zdolsek H.A., and Jenmalm M.C. Reduced levels of soluble CD14 in atopic children. Clin Exp Allergy 34 (2004) 532-539
46. Jones C.A., Holloway J.A., Popplewell E.J., Diaper N.D., Holloway J.W., Vance G.H., et al. Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both. J Allergy Clin Immunol 109 (2002) 858-866
47. Rothenbacher D., Weyermann M., Beermann C., and Brenner H. Breastfeeding, soluble CD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study. Clin Exp Allergy 35 (2005) 1014-1021
48. Liu C., Xu Z., Gupta D., and Dziarski R. Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J Biol Chem 276 (2001) 34686-34694
49. Izadpanah A., and Gallo R.L. Antimicrobial peptides. J Am Acad Dermatol 52 (2005) 381-392
50. Howell M.D., Jones J.F., Kisich K.O., Streib J.E., Gallo R.L., and Leung D.Y. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol 172 (2004) 1763-1767
51. Schibli D.J., Hunter H.N., Aseyev V., Starner T.D., Wiencek J.M., McCray Jr. P.B., et al. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J Biol Chem 277 (2002) 8279-8289
52. Menzies B.E., and Kenoyer A. Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun 73 (2005) 5241-5244
53. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
54. Howell M.D., Novak N., Bieber T., Pastore S., Girolomoni G., Boguniewicz M., et al. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J Invest Dermatol 125 (2005) 738-745
55. Howell M.D., Wollenberg A., Gallo R.L., Flaig M., Streib J.E., Wong C., et al. Cathelicidin deficiency predisposes to eczema herpeticum. J Allergy Clin Immunol 117 (2006) 836-841
56. Rieg S., Steffen H., Seeber S., Humeny A., Kalbacher H., Dietz K., et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol 174 (2005) 8003-8010
57. Michaelsson G. Decreased phagocytic capacity of the neutrophil leucocytes in patients with atopic dermatitis. Acta Derm Venereol 53 (1973) 279-282
58. Mrowietz U., Konter U., Traut R., Schroder J.M., and Christophers E. Atopic dermatitis: influence of bacterial infections on human monocyte and neutrophil granulocyte functional activities. J Allergy Clin Immunol 82 (1988) 1027-1036
59. Rogge J.L., and Hanifin J.M. Immunodeficiencies in severe atopic dermatitis. Depressed chemotaxis and lymphocyte transformation. Arch Dermatol 112 (1976) 1391-1396
60. Bankova LG BM, Platiel M, McGirt LY, Beck LA. Expression of neutrophil chemoattractants and their receptors in subjects with atopic dermatitis and psoriasis [abstract]. J Allergy Clin Immunol 2006;117(suppl):S236
61. Nilsson E.J., Henning C.G., and Magnusson J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 27 (1992) 29-34
62. Remitz A., Kyllonen H., Granlund H., and Reitamo S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 107 (2001) 196-197
63. Schleimer R.P. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 1 (2004) 222-230
64. Rinaldi A.C. Antimicrobial peptides from amphibian skin: an expanding scenario. Curr Opin Chem Biol 6 (2002) 799-804
65. Carretero M., Del Rio M., Garcia M., Escamez M.J., Mirones I., Rivas L., et al. A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides. FASEB J 18 (2004) 1931-1933
66. Savage P.B., Li C., Taotafa U., Ding B., and Guan Q. Antibacterial properties of cationic steroid antibiotics. FEMS Microbiol Lett 217 (2002) 1-7